Investigational Product Supply and Use Authorization Agreement Sample Contracts

Investigational Product Supply and Use Authorization Agreement for OT-101 U.S. Expanded Access (IPSUA) between WideTrial and Oncotelic

Investigational Product Supply and Use Authorization Agreement • September 10th, 2019 • Mateon Therapeutics Inc • Pharmaceutical preparations • Delaware

• Contract Type
  Investigational Product Supply and Use Authorization Agreement
• Filed
  September 10th, 2019
• Company
  Mateon Therapeutics Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Agreement is made and entered into on September 5th, 2019 (the “Effective Date”), by and between WideTrial, Inc., a corporation headquartered at 8 The Green, Suite 8298, Dover, DE 19901 (“WideTrial) (the “Sponsor”), and Oncotelic Inc., headquartered at 29397 Agoura Rd., Ste 107, Agoura Hills, CA 91301 (“Oncotelic”) (the “Manufacturer”)(each a “Party”, collectively “Parties” to this bilateral Agreement).